The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diagnostic Testing For STDs Market Research Report 2024
Synopsis
Sexually transmitted diseases (STDs) are infections that are passed from one person to another through sexual contact.
The global Diagnostic Testing For STDs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Testing For STDs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Testing For STDs.
Report Scope
The Diagnostic Testing For STDs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Testing For STDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Testing For STDs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Diasorin S.p.A
F.Hoffman La-Roche Ltd.
Hologic, Inc.
MedMira, Inc.
Qiagen, Inc.
Siemens Healthcare AG
Segment by Type
Syphilis Testing
Gonorrhea Testing
Chlamydia Testing
Herpes Simplex Virus Testing
Human Immunodeficiency Virus Testing
Human Papilloma Virus Testing
Others
Segment by Application
Laboratory Testing
Point Of Care Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Testing For STDs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Sexually transmitted diseases (STDs) are infections that are passed from one person to another through sexual contact.
The global Diagnostic Testing For STDs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Testing For STDs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Testing For STDs.
Report Scope
The Diagnostic Testing For STDs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Testing For STDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Testing For STDs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Diasorin S.p.A
F.Hoffman La-Roche Ltd.
Hologic, Inc.
MedMira, Inc.
Qiagen, Inc.
Siemens Healthcare AG
Segment by Type
Syphilis Testing
Gonorrhea Testing
Chlamydia Testing
Herpes Simplex Virus Testing
Human Immunodeficiency Virus Testing
Human Papilloma Virus Testing
Others
Segment by Application
Laboratory Testing
Point Of Care Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Testing For STDs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Testing For STDs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Syphilis Testing
1.2.3 Gonorrhea Testing
1.2.4 Chlamydia Testing
1.2.5 Herpes Simplex Virus Testing
1.2.6 Human Immunodeficiency Virus Testing
1.2.7 Human Papilloma Virus Testing
1.2.8 Others
1.3 Market by Application
1.3.1 Global Diagnostic Testing For STDs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Laboratory Testing
1.3.3 Point Of Care Testing
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Testing For STDs Market Perspective (2019-2030)
2.2 Diagnostic Testing For STDs Growth Trends by Region
2.2.1 Global Diagnostic Testing For STDs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diagnostic Testing For STDs Historic Market Size by Region (2019-2024)
2.2.3 Diagnostic Testing For STDs Forecasted Market Size by Region (2025-2030)
2.3 Diagnostic Testing For STDs Market Dynamics
2.3.1 Diagnostic Testing For STDs Industry Trends
2.3.2 Diagnostic Testing For STDs Market Drivers
2.3.3 Diagnostic Testing For STDs Market Challenges
2.3.4 Diagnostic Testing For STDs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Testing For STDs Players by Revenue
3.1.1 Global Top Diagnostic Testing For STDs Players by Revenue (2019-2024)
3.1.2 Global Diagnostic Testing For STDs Revenue Market Share by Players (2019-2024)
3.2 Global Diagnostic Testing For STDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diagnostic Testing For STDs Revenue
3.4 Global Diagnostic Testing For STDs Market Concentration Ratio
3.4.1 Global Diagnostic Testing For STDs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Testing For STDs Revenue in 2023
3.5 Diagnostic Testing For STDs Key Players Head office and Area Served
3.6 Key Players Diagnostic Testing For STDs Product Solution and Service
3.7 Date of Enter into Diagnostic Testing For STDs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Testing For STDs Breakdown Data by Type
4.1 Global Diagnostic Testing For STDs Historic Market Size by Type (2019-2024)
4.2 Global Diagnostic Testing For STDs Forecasted Market Size by Type (2025-2030)
5 Diagnostic Testing For STDs Breakdown Data by Application
5.1 Global Diagnostic Testing For STDs Historic Market Size by Application (2019-2024)
5.2 Global Diagnostic Testing For STDs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diagnostic Testing For STDs Market Size (2019-2030)
6.2 North America Diagnostic Testing For STDs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Diagnostic Testing For STDs Market Size by Country (2019-2024)
6.4 North America Diagnostic Testing For STDs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diagnostic Testing For STDs Market Size (2019-2030)
7.2 Europe Diagnostic Testing For STDs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Diagnostic Testing For STDs Market Size by Country (2019-2024)
7.4 Europe Diagnostic Testing For STDs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Testing For STDs Market Size (2019-2030)
8.2 Asia-Pacific Diagnostic Testing For STDs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Diagnostic Testing For STDs Market Size by Region (2019-2024)
8.4 Asia-Pacific Diagnostic Testing For STDs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diagnostic Testing For STDs Market Size (2019-2030)
9.2 Latin America Diagnostic Testing For STDs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Diagnostic Testing For STDs Market Size by Country (2019-2024)
9.4 Latin America Diagnostic Testing For STDs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Testing For STDs Market Size (2019-2030)
10.2 Middle East & Africa Diagnostic Testing For STDs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Diagnostic Testing For STDs Market Size by Country (2019-2024)
10.4 Middle East & Africa Diagnostic Testing For STDs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories, Inc.
11.1.1 Abbott Laboratories, Inc. Company Detail
11.1.2 Abbott Laboratories, Inc. Business Overview
11.1.3 Abbott Laboratories, Inc. Diagnostic Testing For STDs Introduction
11.1.4 Abbott Laboratories, Inc. Revenue in Diagnostic Testing For STDs Business (2019-2024)
11.1.5 Abbott Laboratories, Inc. Recent Development
11.2 Bio-Rad Laboratories, Inc.
11.2.1 Bio-Rad Laboratories, Inc. Company Detail
11.2.2 Bio-Rad Laboratories, Inc. Business Overview
11.2.3 Bio-Rad Laboratories, Inc. Diagnostic Testing For STDs Introduction
11.2.4 Bio-Rad Laboratories, Inc. Revenue in Diagnostic Testing For STDs Business (2019-2024)
11.2.5 Bio-Rad Laboratories, Inc. Recent Development
11.3 Danaher Corporation
11.3.1 Danaher Corporation Company Detail
11.3.2 Danaher Corporation Business Overview
11.3.3 Danaher Corporation Diagnostic Testing For STDs Introduction
11.3.4 Danaher Corporation Revenue in Diagnostic Testing For STDs Business (2019-2024)
11.3.5 Danaher Corporation Recent Development
11.4 Diasorin S.p.A
11.4.1 Diasorin S.p.A Company Detail
11.4.2 Diasorin S.p.A Business Overview
11.4.3 Diasorin S.p.A Diagnostic Testing For STDs Introduction
11.4.4 Diasorin S.p.A Revenue in Diagnostic Testing For STDs Business (2019-2024)
11.4.5 Diasorin S.p.A Recent Development
11.5 F.Hoffman La-Roche Ltd.
11.5.1 F.Hoffman La-Roche Ltd. Company Detail
11.5.2 F.Hoffman La-Roche Ltd. Business Overview
11.5.3 F.Hoffman La-Roche Ltd. Diagnostic Testing For STDs Introduction
11.5.4 F.Hoffman La-Roche Ltd. Revenue in Diagnostic Testing For STDs Business (2019-2024)
11.5.5 F.Hoffman La-Roche Ltd. Recent Development
11.6 Hologic, Inc.
11.6.1 Hologic, Inc. Company Detail
11.6.2 Hologic, Inc. Business Overview
11.6.3 Hologic, Inc. Diagnostic Testing For STDs Introduction
11.6.4 Hologic, Inc. Revenue in Diagnostic Testing For STDs Business (2019-2024)
11.6.5 Hologic, Inc. Recent Development
11.7 MedMira, Inc.
11.7.1 MedMira, Inc. Company Detail
11.7.2 MedMira, Inc. Business Overview
11.7.3 MedMira, Inc. Diagnostic Testing For STDs Introduction
11.7.4 MedMira, Inc. Revenue in Diagnostic Testing For STDs Business (2019-2024)
11.7.5 MedMira, Inc. Recent Development
11.8 Qiagen, Inc.
11.8.1 Qiagen, Inc. Company Detail
11.8.2 Qiagen, Inc. Business Overview
11.8.3 Qiagen, Inc. Diagnostic Testing For STDs Introduction
11.8.4 Qiagen, Inc. Revenue in Diagnostic Testing For STDs Business (2019-2024)
11.8.5 Qiagen, Inc. Recent Development
11.9 Siemens Healthcare AG
11.9.1 Siemens Healthcare AG Company Detail
11.9.2 Siemens Healthcare AG Business Overview
11.9.3 Siemens Healthcare AG Diagnostic Testing For STDs Introduction
11.9.4 Siemens Healthcare AG Revenue in Diagnostic Testing For STDs Business (2019-2024)
11.9.5 Siemens Healthcare AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
